XIDX
UNIC
Market cap199mUSD
Nov 12, Last price
9,300.00IDR
Name
Unggul Indah Cahaya Tbk PT
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Unggul Indah Cahaya Tbk engages in the manufacture and sale of alkylbenzene chemicals in Indonesia and internationally. The company operates in two segments, Chemicals and Real Estate. It offers linear and branched alkylbenzene, as well as heavy and light alkylate for use as raw materials to produce detergents. The company also manufactures and distributes active detergents of linear alkylbenzene sulfonic acid and sodium lauryl ether sulfate, sodium tripolyphosphate, phosphoric acid, and phosphates and surfactants. In addition, it is involved in the development of real estate properties. The company also operates in the United States, Australia, Singapore, Vietnam, New Zealand, and Japan. PT Unggul Indah Cahaya Tbk was founded in 1983 and is headquartered in Jakarta Selatan, Indonesia.
Key people
President Commissioner, Independent Commissioner · since 2013
Yani Alifen
President Director · since 2006
Hanny Sutanto
Vice President Commissioner · since 1995
Djazoeli Sadhani
Vice President Director · since 2013
Director · since 1995
Lily Setiadi
Director · since 2016
Fifi Afriyanthi
Corporate Secretary · since 2016
Teddy Jeffrey Katuari
Commissioner · since 2006
Commissioner · since 1991
Commissioner · since 2011
Farid Harianto
Independent Commissioner · since 2005
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||